Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 38

1.

Reward-based improvements in motor control are driven by multiple error-reducing mechanisms.

Codol O, Holland PJ, Manohar SG, Galea JM.

J Neurosci. 2020 Mar 27. pii: JN-RM-2646-19. doi: 10.1523/JNEUROSCI.2646-19.2020. [Epub ahead of print]

PMID:
32234779
2.

The relationship between reinforcement and explicit control during visuomotor adaptation.

Codol O, Holland PJ, Galea JM.

Sci Rep. 2018 Jun 14;8(1):9121. doi: 10.1038/s41598-018-27378-1.

3.

What nurses and midwives want: Findings from the national survey on workplace climate and well-being.

Holland PJ, Tham TL, Gill FJ.

Int J Nurs Pract. 2018 Jun;24(3):e12630. doi: 10.1111/ijn.12630. Epub 2018 Feb 26.

PMID:
29479760
4.

Review of epidemiology, clinical presentation, diagnosis, and treatment of common primary psychiatric causes of cutaneous disease.

Krooks JA, Weatherall AG, Holland PJ.

J Dermatolog Treat. 2018 Jun;29(4):418-427. doi: 10.1080/09546634.2017.1395389. Epub 2017 Nov 5. Review.

PMID:
29052453
5.

Genome-wide association studies of autoimmune vitiligo identify 23 new risk loci and highlight key pathways and regulatory variants.

Jin Y, Andersen G, Yorgov D, Ferrara TM, Ben S, Brownson KM, Holland PJ, Birlea SA, Siebert J, Hartmann A, Lienert A, van Geel N, Lambert J, Luiten RM, Wolkerstorfer A, Wietze van der Veen JP, Bennett DC, Taïeb A, Ezzedine K, Kemp EH, Gawkrodger DJ, Weetman AP, Kõks S, Prans E, Kingo K, Karelson M, Wallace MR, McCormack WT, Overbeck A, Moretti S, Colucci R, Picardo M, Silverberg NB, Olsson M, Valle Y, Korobko I, Böhm M, Lim HW, Hamzavi I, Zhou L, Mi QS, Fain PR, Santorico SA, Spritz RA.

Nat Genet. 2016 Nov;48(11):1418-1424. doi: 10.1038/ng.3680. Epub 2016 Oct 10.

6.

Superposition Violations in the Compensatory Eye Movement System.

Sibindi TM, Holland PJ, van der Geest JN, Donchin O, Frens MA.

Invest Ophthalmol Vis Sci. 2016 Jul 1;57(8):3554-66. doi: 10.1167/iovs.15-18605.

PMID:
27379580
7.

Influence of sex and menopausal status on response, remission, and recurrence in patients with recurrent major depressive disorder treated with venlafaxine extended release or fluoxetine: analysis of data from the PREVENT study.

Kornstein SG, Pedersen RD, Holland PJ, Nemeroff CB, Rothschild AJ, Thase ME, Trivedi MH, Ninan PT, Keller MB.

J Clin Psychiatry. 2014 Jan;75(1):62-8. doi: 10.4088/JCP.12m07841.

PMID:
24345717
8.

NLRP1 haplotypes associated with vitiligo and autoimmunity increase interleukin-1β processing via the NLRP1 inflammasome.

Levandowski CB, Mailloux CM, Ferrara TM, Gowan K, Ben S, Jin Y, McFann KK, Holland PJ, Fain PR, Dinarello CA, Spritz RA.

Proc Natl Acad Sci U S A. 2013 Feb 19;110(8):2952-6. doi: 10.1073/pnas.1222808110. Epub 2013 Feb 4.

9.

Association of generalized vitiligo with MHC class II loci in patients from the Indian subcontinent.

Birlea SA, Ahmad FJ, Uddin RM, Ahmad S, Pal SS, Begum R, Laddha NC, Dwivedi M, Shoab Mansuri M, Jin Y, Gowan K, Riccardi SL, Holland PJ, Ben S, Fain PR, Spritz RA.

J Invest Dermatol. 2013 May;133(5):1369-72. doi: 10.1038/jid.2012.501. Epub 2013 Jan 10. No abstract available.

10.

In vitro electroporation of the lower rhombic lip of midgestation mouse embryos.

Holland PJ, George AM, Worrell LT, Landsberg RL.

J Vis Exp. 2012 Aug 3;(66):e3983. doi: 10.3791/3983.

11.

Dopamine receptor-interacting protein 78 acts as a molecular chaperone for CCR5 chemokine receptor signaling complex organization.

Kuang YQ, Charette N, Frazer J, Holland PJ, Attwood KM, Dellaire G, Dupré DJ.

PLoS One. 2012;7(7):e40522. doi: 10.1371/journal.pone.0040522. Epub 2012 Jul 16.

12.

Genome-wide association analyses identify 13 new susceptibility loci for generalized vitiligo.

Jin Y, Birlea SA, Fain PR, Ferrara TM, Ben S, Riccardi SL, Cole JB, Gowan K, Holland PJ, Bennett DC, Luiten RM, Wolkerstorfer A, van der Veen JP, Hartmann A, Eichner S, Schuler G, van Geel N, Lambert J, Kemp EH, Gawkrodger DJ, Weetman AP, Taïeb A, Jouary T, Ezzedine K, Wallace MR, McCormack WT, Picardo M, Leone G, Overbeck A, Silverberg NB, Spritz RA.

Nat Genet. 2012 May 6;44(6):676-80. doi: 10.1038/ng.2272.

13.

Structural reorganization of the interleukin-7 signaling complex.

McElroy CA, Holland PJ, Zhao P, Lim JM, Wells L, Eisenstein E, Walsh ST.

Proc Natl Acad Sci U S A. 2012 Feb 14;109(7):2503-8. doi: 10.1073/pnas.1116582109. Epub 2012 Jan 30.

14.

Biophysical characterization of glycosaminoglycan-IL-7 interactions using SPR.

Zhang F, Liang X, Pu D, George KI, Holland PJ, Walsh ST, Linhardt RJ.

Biochimie. 2012 Jan;94(1):242-9. doi: 10.1016/j.biochi.2011.10.015. Epub 2011 Nov 6.

15.

Aicardi-Goutieres syndrome gene and HIV-1 restriction factor SAMHD1 is a dGTP-regulated deoxynucleotide triphosphohydrolase.

Powell RD, Holland PJ, Hollis T, Perrino FW.

J Biol Chem. 2011 Dec 23;286(51):43596-600. doi: 10.1074/jbc.C111.317628. Epub 2011 Nov 7.

16.

5-HT2A receptor signalling through phospholipase D1 associated with its C-terminal tail.

Barclay Z, Dickson L, Robertson DN, Johnson MS, Holland PJ, Rosie R, Sun L, Fleetwood-Walker S, Lutz EM, Mitchell R.

Biochem J. 2011 Jun 15;436(3):651-60. doi: 10.1042/BJ20101844.

PMID:
21410433
17.

Genome-wide analysis identifies a quantitative trait locus in the MHC class II region associated with generalized vitiligo age of onset.

Jin Y, Birlea SA, Fain PR, Gowan K, Riccardi SL, Holland PJ, Bennett DC, Herbstman DM, Wallace MR, McCormack WT, Kemp EH, Gawkrodger DJ, Weetman AP, Picardo M, Leone G, Taïeb A, Jouary T, Ezzedine K, van Geel N, Lambert J, Overbeck A, Spritz RA.

J Invest Dermatol. 2011 Jun;131(6):1308-12. doi: 10.1038/jid.2011.12. Epub 2011 Feb 17.

18.

Common variants in FOXP1 are associated with generalized vitiligo.

Jin Y, Birlea SA, Fain PR, Mailloux CM, Riccardi SL, Gowan K, Holland PJ, Bennett DC, Wallace MR, McCormack WT, Kemp EH, Gawkrodger DJ, Weetman AP, Picardo M, Leone G, Taïeb A, Jouary T, Ezzedine K, van Geel N, Lambert J, Overbeck A, Spritz RA.

Nat Genet. 2010 Jul;42(7):576-8. doi: 10.1038/ng.602. Epub 2010 Jun 6.

19.

Variant of TYR and autoimmunity susceptibility loci in generalized vitiligo.

Jin Y, Birlea SA, Fain PR, Gowan K, Riccardi SL, Holland PJ, Mailloux CM, Sufit AJ, Hutton SM, Amadi-Myers A, Bennett DC, Wallace MR, McCormack WT, Kemp EH, Gawkrodger DJ, Weetman AP, Picardo M, Leone G, Taïeb A, Jouary T, Ezzedine K, van Geel N, Lambert J, Overbeck A, Spritz RA.

N Engl J Med. 2010 May 6;362(18):1686-97. doi: 10.1056/NEJMoa0908547. Epub 2010 Apr 21.

20.
21.

Role of the conserved NPxxY motif of the 5-HT2A receptor in determining selective interaction with isoforms of ADP-ribosylation factor (ARF).

Johnson MS, Robertson DN, Holland PJ, Lutz EM, Mitchell R.

Cell Signal. 2006 Oct;18(10):1793-800. Epub 2006 Mar 20.

PMID:
16545942
22.

Characterization of novel splice variants of the PAC1 receptor in human neuroblastoma cells: consequences for signaling by VIP and PACAP.

Lutz EM, Ronaldson E, Shaw P, Johnson MS, Holland PJ, Mitchell R.

Mol Cell Neurosci. 2006 Feb;31(2):193-209. Epub 2005 Oct 14.

PMID:
16226889
23.

Efficacy, safety, and tolerability of sertraline in patients with late-life depression and comorbid medical illness.

Sheikh JI, Cassidy EL, Doraiswamy PM, Salomon RM, Hornig M, Holland PJ, Mandel FS, Clary CM, Burt T.

J Am Geriatr Soc. 2004 Jan;52(1):86-92. Erratum in: J Am Geriatr Soc. 2004 Jul;52(7):1228.

PMID:
14687320
24.

Selective interaction of ARF1 with the carboxy-terminal tail domain of the 5-HT2A receptor.

Robertson DN, Johnson MS, Moggach LO, Holland PJ, Lutz EM, Mitchell R.

Mol Pharmacol. 2003 Nov;64(5):1239-50.

PMID:
14573774
25.

ADP-ribosylation factor-dependent phospholipase D activation by the M3 muscarinic receptor.

Mitchell R, Robertson DN, Holland PJ, Collins D, Lutz EM, Johnson MS.

J Biol Chem. 2003 Sep 5;278(36):33818-30. Epub 2003 Jun 10.

26.

Functional interactions between native Gs-coupled 5-HT receptors in HEK-293 cells and the heterologously expressed serotonin transporter.

Johnson MS, Lutz EM, Firbank S, Holland PJ, Mitchell R.

Cell Signal. 2003 Aug;15(8):803-11.

PMID:
12781873
27.

Specific interaction between the hop1 intracellular loop 3 domain of the human PAC(1) receptor and ARF.

Ronaldson E, Robertson DN, Johnson MS, Holland PJ, Mitchell R, Lutz EM.

Regul Pept. 2002 Nov 15;109(1-3):193-8.

PMID:
12409233
28.

Additional signals from VPAC/PAC family receptors.

McCulloch DA, MacKenzie CJ, Johnson MS, Robertson DN, Holland PJ, Ronaldson E, Lutz EM, Mitchell R.

Biochem Soc Trans. 2002 Aug;30(4):441-6. Review.

PMID:
12196111
29.

ADP-ribosylation factor-dependent phospholipase D activation by VPAC receptors and a PAC(1) receptor splice variant.

McCulloch DA, Lutz EM, Johnson MS, Robertson DN, MacKenzie CJ, Holland PJ, Mitchell R.

Mol Pharmacol. 2001 Jun;59(6):1523-32.

PMID:
11353814
30.

Mechanisms of phospholipase C activation by the vasoactive intestinal polypeptide/pituitary adenylate cyclase-activating polypeptide type 2 receptor.

MacKenzie CJ, Lutz EM, Johnson MS, Robertson DN, Holland PJ, Mitchell R.

Endocrinology. 2001 Mar;142(3):1209-17.

PMID:
11181537
31.

Gonadotropin-releasing hormone receptor activation of extracellular signal-regulated kinase and tyrosine kinases in transfected GH3 cells and in alphaT3-1 cells.

Johnson MS, Lutz EM, MacKenzie CJ, Wolbers WB, Robertson DN, Holland PJ, Mitchell R.

Endocrinology. 2000 Sep;141(9):3087-97.

PMID:
10965878
32.

ECT in a geriatric depressed woman with bilateral frontal lobotomy.

Llorente MD, Holland PJ.

Convuls Ther. 1996 Mar;12(1):36-9. No abstract available.

PMID:
8777652
33.

Inhibition of Listeria monocytogenes in Cold-process (Smoked) Salmon by Sodium Lactate.

Pelroy GA, Peterson ME, Holland PJ, Eklund MW.

J Food Prot. 1994 Feb;57(2):108-113. doi: 10.4315/0362-028X-57.2.108.

PMID:
31113144
34.

Comparison of Selective Direct Plating Media for Enumeration and Recovery of L. monocytogenes from Cold-process (smoked) Fish.

Paranjpye RN, Pelroy GA, Peterson ME, Poysky FT, Holland PJ, Lashbrook LC, Eklund MW.

J Food Prot. 1992 Nov;55(11):905-909. doi: 10.4315/0362-028X-55.11.905.

PMID:
31084057
35.

Effect on gastric and duodenal mucosal prostaglandins of repeated intake of therapeutic doses of naproxen and etodolac in rheumatoid arthritis.

Taha AS, McLaughlin S, Holland PJ, Kelly RW, Sturrock RD, Russell RI.

Ann Rheum Dis. 1990 Jun;49(6):354-8.

36.

Imipramine: withdrawal and urticaria.

Burnett GB, Holland PJ.

South Med J. 1985 Jan;78(1):71-2. No abstract available.

PMID:
3966176
37.

Lithium capsule.

Holland PJ.

Am Fam Physician. 1981 Sep;24(3):147-8. No abstract available.

PMID:
7270375
38.

MSG: a possibility in treating tardive dyskinesia.

Holland PJ.

Am J Psychiatry. 1979 Dec;136(12):1612. No abstract available.

PMID:
507228

Supplemental Content

Loading ...
Support Center